First Brain Tumor Treated with Xoft IORT in the United States

NEXT STORY
SELLAS Announces Enrollment of First Patient in Phase 1 Trial of Galinpepimut-S (GPS) in Combination with Nivolumab (Opdivo®) in Patients with Malignant Pleural Mesothelioma (MPM)
PREV STORY
Next-Generation Sequencing Market Size Report 2020 – 2026 | NGS Industry Share, Growth, Insights and Forecast
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Vaxart Announces First Subject Enrolled in Phase 1b Norovirus Boosting Regimen Study

author_avatar
NASDAQ Market News

CRISPR Therapeutics Presents Positive Data on Allogeneic CRISPR-based CAR-T Cell Therapies at AACR 2018

author_avatar
NASDAQ Market News

Cue Biopharma Announces First Patient Dosed in Part B Patient Expansion of CUE-101 Phase 1 Monotherapy Trial in HPV+ Second Line and Beyond HNSCC

author_avatar
NASDAQ Market News